Market Overview: 

The Indian vaccine market is expected to exhibit a CAGR of 13.4% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

A vaccine is a biological substance that is developed to boost the immune system while protecting against bacterial and viral diseases. It comprises live attenuated, inactivated, toxoid, mRNA, viral vector, and subunit, recombinant, polysaccharide, and conjugate vaccines. It is consumed orally, by aerosol, or through injections to prevent several diseases, such as measles, polio, tetanus, influenza, rabies, and whooping cough. In addition, it stimulates the body to make antibodies against antigens or pathogens. At present, there is a rise in the production of vaccines in India due to technological advancements and the increasing number of cold chain storage facilities.

Indian Vaccine Market Trends:

The Government of India (GOI) is currently launching various campaigns, such as the Universal Immunization Program (UIP), to increase immunization coverage against vaccine-preventable diseases in the country. This, along with the growing health awareness among the masses, represents one of the key factors driving the market in India. Moreover, the rising export of generic medicines in India that imitates brand-name drugs in effect, strength, doses, qualities, forms, administration, and safety is contributing to the growth of the market. In addition, there is an increase in the number of private companies that are producing cost-effective vaccines and investing in their distribution throughout India. This, coupled with the burgeoning healthcare industry, is strengthening the growth of the market in the country. Besides this, key market players are extensively investing in research and development (R&D) activities to introduce new and enhanced vaccines. They are also focusing on developing innovative ways to distribute vaccines effectively within the country and international markets, which is catalyzing the demand for Indian vaccines. Other factors propelling the market growth are the increasing population, inflating income levels of individuals, improving existing vaccine infrastructure, the expanding logistics industry, and the growing participation of non-governmental organizations (NGOs).

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the Indian vaccine market report, along with forecasts at the global, regional, and country levels from 2022-2027. Our report has categorized the market based on monovalent and combined vaccines.

Breakup by Monovalent and Combined Vaccines:

• BCG 
• HIB 
• Influenza 
• Varicella 
• Typhoid 
• Japanese Encephalitis
• Measles 
• Tetanus Toxoid 
• Hepatitis A 
• Rubella 
• Diphtheria 
• Tetanus, and Pertussis (DPT) 
• Oral Polio Vaccine (OPV) 
• MMR 
• Rotavirus 
• Hepatitis B 
• Pneumococcal 
• Meningococcal 
• Rabies
• HPV
• Hexavalent
• Dengue vaccines

The Focus of the Analysis for Each Vaccine

• Vaccine Overview 
• Historical and Current Market Trends
• Market Breakup by Prescriber
• Market Breakup by Public and Private Sector
• Market Outlook